Vancomycin (VCM) is a first-line antibiotic for serious infections caused by methicillin-resistant Staphylococcus aureus. However, nephrotoxicity is one of the most complaint in VCM therapy. We previously reported that VCM induced apoptosis in a porcine proximal tubular epithelial cell line (LLC-PK1), in which mitochondrial complex I may generate superoxide, leading to cell death. In the present study, VCM caused production of mitochondrial reactive oxygen species and peroxidation of the mitochondrial phospholipid cardiolipin that was reversed by administration of the mitochondrial uncoupler carbonyl cyanide-4-(trifluoromethoxy) phenylhydrazone (FCCP). FCCP also significantly suppressed VCM-induced depolarization of the mitochondrial membrane and apoptosis. Moreover, the lipophilic antioxidant vitamin E and a mitochondria-targeted antioxidant, mitoTEMPO, also significantly suppressed VCM-induced depolarization of mitochondrial membrane and apoptosis, whereas vitamin C, n-acetyl cysteine, or glutathione did not provide significant protection. These findings suggest that peroxidation of the mitochondrial membrane cardiolipin mediated the VCMinduced production of intracellular reactive oxygen species and initiation of apoptosis in LLC-PK1 cells. Furthermore, regulation of mitochondrial function using a mitochondria-targeted antioxidant, such as mitoTEMPO, may constitute a potential strategy for mitigation of VCM-induced proximal tubular epithelial cell injury.
Introduction
Vancomycin (VCM) is a glycopeptide antibiotic used as a first-line therapy for serious infections caused by methicillin-resistant Staphylococcus aureus (MRSA). However, nephrotoxicity is one of the most common complaint associated with VCM therapy. Recent guidelines have recommended maintaining higher VCM trough levels (15-20 mg/l) and achieving an area under the curve/minimum inhibitory concentration of ≥400 in the treatment of complicated MRSA infections (Rybak et al., 2009; Álvarez et al., 2016) . However, higher VCM doses and trough concentrations could increase the likelihood of nephrotoxicity, particularly in patients at high risk for acute kidney injury (Álvarez et al., 2016; Elyasi et al., 2012; WongBeringer et al., 2011) . A recent meta-analysis of 15 clinical studies showed that VCM-associated nephrotoxicity is significantly more prevalent in patients with high VCM trough levels (≥15 mg/l) than in patients with low trough levels ( < 15 mg/l) (van Hal et al., 2013) . Therapeutic drug monitoring is useful for prevention of nephrotoxicity induced by VCM; however, it is difficult to ensure the clinical efficacy of VCM and simultaneously decrease nephrotoxicity in clinical settings. Although the precise mechanisms underlying VCM-associated nephrotoxicity are largely unknown, renal tubular cell damage and oxidative stress have been implicated in the pathogenesis (Cetin et al., 2007; Oktem et al., 2005; Dieterich et al., 2009) .
We previously reported that VCM induced apoptotic injury in the porcine proximal tubular epithelial cell line LLC-PK1 (Arimura et al., 2012) . In particular, VCM increased intracellular reactive oxygen species production, leading to depolarization of the mitochondrial membrane and activation of caspase-9 and −3/7. Moreover, we demonstrated that mitochondrial respiratory chain complex I may play a key role in VCM-induced superoxide generation and proximal tubular epithelial cell apoptosis (Arimura et al., 2012) . The present study was designed to clarify the mechanisms underlying VCM-induced proximal tubular cell damage and to determine whether regulation of mitochondrial function can mitigate VCM-induced renal tubular epithelial cell injury.
Materials and methods

Chemicals
VCM hydrochloride, α-tocopherol (vitamin E), n-acetyl cysteine (NAC), glutathione (GSH), and sodium azide were purchased from Wako Pure Chemicals (Osaka, Japan). Carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazine (FCCP), rotenone, 3-nitropropionic acid, and anti-β-actin monoclonal antibody were obtained from SigmaAldrich (St. Louis, MO, USA). Antimycin A was obtained from LKT Laboratories, Inc. (St. Paul, MN, USA). Ascorbic acid (vitamin C) was purchased from Nacalai Tesque (Kyoto, Japan). Horseradish peroxidase-conjugated goat anti-mouse antibodies were obtained from Jackson Immuno Research Laboratories, Inc. (West Grove, PA, USA). Anti-cytochrome c monoclonal antibody was purchased from Bio Vision, Inc. (Milpitas, CA, USA). 5-(and-6)-carboxy-2′,7′-dichlorodihydrofluorescein diacetate (carboxy-H 2 DCFDA), MitoSOX Red, and 10-N-nonyl acridine orange (NAO) were purchased from Life Technologies (Carlsbad, CA, USA). Hoechst 33342 was obtained from Dojindo Laboratories (Kumamoto, Japan).
(2-(2,2,6,6-Tetramethylpiperidin-1-oxyl-4-ylamino)−2-oxoethyl)triphenylphosphonium chloride (MitoTEMPO) was purchased from Enzo Life Sciences, Inc. (Farmingdale, NY). Caspase inhibitors, namely, zDEVD-fmk (selective for caspase-3) and zLEHD-fmk (selective for caspase-9), were purchased from Merck Millipore (Billerica, MA, USA).
Cell culture
The porcine proximal tubular epithelial LLC-PK1 cell line was obtained from the American Type Culture Collection (Rockville, MD, USA). Cells were maintained in Medium 199 (MP Biomedicals, lrvine, CA, USA) containing 10% fetal bovine serum under an atmosphere of 5% CO 2 at 37°C. Cells were seeded at a density of 2.0×10 4 cells/cm 2 onto cell culture dishes or plates and used for experiments on the following day, when they had reached 70-80% confluence.
Cell viability
Cell viability was assessed using Presto Blue cell viability reagent (Life Technologies) according to the manufacturer's instructions. Presto Blue is reduced from resazurin, a blue compound with no intrinsic fluorescence, to resorufin, which is red in color and highly fluorescent upon entering living cells (Lall et al., 2013) . Cells were seeded onto 96-well plastic plates (Corning, Inc., Corning, NY, USA). After VCM treatment, cells were washed with phosphate-buffered saline (PBS) and incubated with 90 μl of serum-free medium and 10 μl of Presto Blue reagent for 1 h at 37°C in humidified air supplemented with 5% CO 2 . The incubation medium was transferred to 96-well flat-bottom black plates (Nalge Nunc International, Penfield, NY, USA). Resorufin fluorescence was measured at an excitation wavelength of 544 nm and an emission wavelength of 590 nm using a microplate reader (Flex station 3; Molecular Devices, Sunnyvale, CA, USA).
Western blot analysis of cytochrome c
Release of cytochrome c from the mitochondria to the cytoplasm was assessed by western blot. Cells were lysed and the cytosolic fractions were isolated using a mitochondria/cytosol-fractionation kit (Bio Vision) according to the manufacturer's instructions. Briefly, cells (~2.0×10 6 ) were collected by cell scraper and centrifuged at 150g for 5 min. Cell pellets were homogenized and centrifuged at 700g for 10 min. The supernatant was centrifuged at 10,000g for 30 min to isolate the mitochondrial fraction. Proteins from the cytosolic fractions were subjected to 13.5% SDS-PAGE and transferred electrophoretically to polyvinylidene difluoride membranes. The membranes were blocked in Tris-buffered saline Tween-20 containing 5% bovine serum albumin or non-fat dry milk for 1 h at room temperature with agitation. The membrane was incubated overnight at 4°C with an anti-cytochrome c or β-actin antibody (1:5000) and then incubated for 1 h with antimouse IgG horseradish peroxidase (1:5000). To ensure equal protein loading, β-actin (cytosolic fraction) was used as an internal control. Immunoreactivity was detected using enhanced chemiluminescence (Perkin Elmer, Waltham, MA, USA) and a chemiluminescence detector (LAS 4000; GE Healthcare Life Sciences, Pittsburgh, PA, USA).
Terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) assay
The quantification of apoptotic cell death was assessed by TUNEL staining, as described previously (Arimura et al., 2012) . Briefly, after exposure to VCM, cells were permeabilized with 70% ethanol overnight at −20°C. The TUNEL assay was performed using the Dead End fluorometric system (Promega Corp., Madison, WI, USA) according to the manufacturer's instructions. The fluorescent cells were quantitatively analyzed using flow cytometry (Becton-Dickinson, Franklin Lakes, NJ, USA), and Cell Quest software (Becton-Dickinson).
2.6. Determination of intracellular reactive oxygen species and mitochondrial superoxide production Intracellular reactive oxygen species and mitochondrial superoxide were determined using carboxy-H 2 DCFDA fluorescence labeling or a selective mitochondrial superoxide probe, MitoSOX red (Life Technologies) as described previously. Briefly, cells were seeded onto 12-well plastic plates (Becton-Dickinson). At 24 h after seeding, the cells were exposed to VCM for the indicated duration. The cells were washed twice with PBS and treated with carboxy-H 2 DCFDA (50 μM) for 1 h or MitoSOX Red (2 μM) for 15 min at 37°C. Cells were trypsinized and resuspended in PBS, and then analyzed by flow cytometry (Becton-Dickinson). At least 10,000 cells were collected for each sample, and data were analyzed by Cell Quest software (BectonDickinson).
Assay for caspase-3/7 activity
Caspase-3/7 activities were assessed by the Apo-ONE homogeneous caspase-3/7 assay kit (Promega) according to the manufacturer's instructions. Briefly, after exposure to VCM, cells were washed with PBS and incubated with caspase substrate for 1 h at room temperature. Caspase-3/7 activities were measured at an excitation wavelength of 490 nm and an emission wavelength of 530 nm using a fluorescence plate reader (MTP-601F; Hitachi High-Technologies Corp., Tokyo, Japan).
Assessment of cardiolipin peroxidation
Cardiolipin peroxidation was assessed using NAO, which is a cellpermeating fluorescent indicator that accumulates in mitochondria and binds to cardiolipin. Peroxidation of cardiolipin causes a decrease in the binding affinity of NAO to cardiolipin, resulting in decreased fluorescence (Ferlini and Scambia, 2007) . In brief, after exposure to VCM, cells were washed twice with PBS and loaded with NAO (30 nM) for 15 min at 37°C. Cells were visualized using an all-in-one florescence microscope (BZ-9000; Keyence, Tokyo, Japan). The mean fluorescence intensity around nucleoli was measured using ImageJ software (Image J v1.43; National Institutes of Health, Bethesda, MD, USA). Data were calculated as the average value for five fields. The nucleoli of the cells were counterstained using Hoechst 33342 (0.5 µg/ ml).
Assessment of mitochondrial membrane potential
Changes in the mitochondrial membrane potential were assessed by using a JC-1 mitochondrial membrane potential assay kit (Cayman Chemical Company, Ann Arbor, MI, USA) according to the manufacturer's instructions. Briefly, cells were seeded onto 24-well plates and treated with VCM for the indicated durations. JC-1-staining solution was prepared by diluting the reagent 1:200 in the culture medium without serum. Cells were washed twice with PBS, and 300 μl of JC-1-staining solution was added to each well. After 45 min of incubation at 37°C, cells were visualized using an all-in-one florescence microscope (Keyence). The JC-1 red-to-green fluorescence intensity ratio was calculated using ImageJ software (National Institutes of Health). Data were calculated as the average value for five fields.
Measurement of intracellular adenosine triphosphate (ATP) content
Intracellular ATP content was assessed by an ATP assay kit (Toyo B-net Co., Ltd., Tokyo, Japan) according to the manufacturer's instructions. Briefly, cells were seeded onto 96-well plastic plates (Corning) and treated with VCM for the indicated durations. The cells were washed twice with PBS, and 50 μl of Krebs-Ringer buffer and 50 μl of ATP assay reagent were added. After mixing for 1 min, cells were incubated for 10 min at room temperature. The incubation medium was transferred to 96-well flat-bottom white plates (Nalge Nunc International), and luminescence derived from the ATP-luciferase reaction was measured using a microplate reader (Flex station 3; Molecular Devices).
Assessment of proximal tubular cell damage in rats
Male Wistar rats weighing 200-250 g (Kyudo Co., Saga, Japan) were housed on a room maintained on 12-h light/dark schedule (lights on at 7:00 a.m.) at a room temperature of 24 ± 1°C and humidity of 60 ± 10% with food and water available ad libitum. Rats were injected i.p. with 200 mg/kg VCM twice a day for five days. After 12 h from last injection, urine sample was collected by metabolic cage. The activity of N-acetyl-β-D-glucosaminidase (NAG) in urine was determined by the enzymatic degradation of the substrate using a commercial assay kit (Wako). NAG activity was expressed as units per g urinary creatinine. All in vivo experiments were approved by the Experimental Animal Care and Use Committee of Kyushu University according to the National Institutes of Health guidelines (Permit Number: A28-003-1).
Statistical analysis
Data are expressed as the mean ± standard error of the mean (S.E.M.) and were statistically analyzed by one-way analysis of variance, followed by Tukey-Kramer tests for multiple comparisons or by Student's t-test for comparison between two groups. Statistical significance was defined as P < 0.05.
Results
VCM-induced apoptosis in LLC-PK1 cells
Exposure of LLC-PK1 cells to VCM (1−5 mM) induced a concentration-dependent decrease in cell viability at 48 h as determined by Presto Blue assay (Fig. 1A) . Significant decreases in viability were observed at concentrations > 2 mM. As shown in Fig. 1B , cell injury caused by 4 mM VCM increased over time, with significant alterations observed starting at 3 h after VCM treatment. To identify apoptotic cell death associated with the toxic effects of VCM in LLC-PK1 cells, we examined the release of cytochrome c from mitochondria to the cytosol by western blot and TUNEL assay with flow cytometry. VCM administration increased cytosolic cytochrome c (Fig. 1C ) levels and the number of TUNEL-positive cells (Fig. 1D) .
VCM-induced intracellular reactive oxygen species generation in LLC-PK1 cells
To evaluate intracellular oxidative stress during VCM-induced cell death, we examined reactive oxygen species generation using a carboxy-H 2 DCFDA probe and mitochondrial superoxide generation using MitoSOX Red reagent, in which the results were analyzed by flow cytometry. As shown in Fig. 2A , VCM (4 mM) increased DCF fluorescence intensity over time, with significant elevation of DCF fluorescence observed starting 3 h after VCM treatment. MitoSOX fluorescence intensity also increased over time after VCM treatment (Fig. 2B) . Moreover, the VCM-induced elevation of both MitoSOX and DCF fluorescence intensity was significantly suppressed by administration of the lipophilic antioxidant vitamin E (100 µM).
Induction of mitochondrial cardiolipin peroxidation in LLC-PK1 cells by VCM
Mitochondria are the main sites of reactive oxygen species production, and superoxide is the primary reactive oxygen species generated by mitochondria (Lu et al., 2015) . To determine the role of mitochondria in VCM-induced reactive oxygen species production, we assessed levels of the mitochondrial membrane phospholipid cardiolipin using NAO staining. As shown in Fig. 3A , VCM (4 mM) decreased NAO fluorescence intensity over time, with significant changes observed starting 12 h after VCM treatment. Moreover, the decrease in NAO fluorescence intensity was significantly reversed by administration of the mitochondrial uncoupler FCCP (0.5 µM) (Fig. 3B) .
VCM-induced depolarization of the mitochondrial membrane and reduction of cellular ATP levels
We previously reported that VCM decreases the mitochondrial membrane potential in LLC-PK1 cells over time (Arimura et al., 2012) . In the present study, treatment of LLC-PK1 cells with VCM (4 mM, 24 h) decreased the ratio of JC-1 red (aggregates) to green (monomers) fluorescence intensity, suggesting that VCM caused depolarization of mitochondrial membranes. Moreover, the changes in JC-1 fluorescence intensity were significantly reversed by administration of FCCP (0.5 µM) (Fig. 4A) . As shown in Fig. 4B , a significant decrease in intracellular ATP levels was observed at 12 h after VCM treatment (4 mM). In contrast, FCCP (0.5 µM) treatment caused changes in cellular ATP levels similar to those observed following VCM treatment, and the depletion of ATP by VCM was significantly exacerbated in the presence of FCCP.
3.5. Effect of FCCP treatment on VCM-induced intracellular reactive oxygen species production and apoptosis in LLC-PK1 cells Treatment of LLC-PK1 cells with VCM (4 mM) for 3 h significantly increased both MitoSOX (Fig. 5A) and DCF (Fig. 5B) fluorescence intensity, and this effect was completely reversed by FCCP (0.5 µM) administration. As shown in Fig. 5C , FCCP (0.25-0.5 µM) also significantly suppressed the induction of TUNEL-positive apoptotic cells by VCM (4 mM, 48 h). We also examined the effects of the electron transport inhibitors including rotenone (complex I inhibitor), 3-nitropropionic acid (complex II inhibitor), antimycin A (complex III inhibitor) and sodium azide (complex IV inhibitor) on apoptosis assessed by TUNEL assay and on mitochondrial superoxide production assessed by MitoSOX red assay in LLC-PK1 cells. The values in TUNEL assay were 100.0 ± 5.4% (mean ± S.E.M., N=4) for vehicle, 163.7 ± 4.6% (N=4, **P < 0.01 vs. vehicle) for rotenone (0.5 µM, 24 h), 182.4 ± 10.2% (N=4, **P < 0.01 vs. vehicle) for 3-nitropropionic acid (10 mM, Fig. 2 . VCM-induced intracellular reactive oxygen species production in LLC-PK1 cells. Reactive oxygen species production was determined by flow cytometry using (A) the cellpermeable reactive oxygen species probe carboxy-H 2 DCF-DA and (B) the mitochondrial superoxide indicator MitoSOX Red. Cells were treated for the indicated times with VCM (4 mM) in the absence or presence of vitamin E (100 µM). Data represent the mean ± S.E.M. of four experiments. **P < 0.01 vs. vehicle, †P < 0.05, † †P < 0.01 vs. VCM-treated group. 24 h), 134.6 ± 6.9% (N=4, *P < 0.05 vs. vehicle) for antimycin A (30 µM, 24 h), and 134.6 ± 7.0% (N=4, *P < 0.05 vs. vehicle) for sodium azide (50 mM, 24 h). The values in MitoSOX red assay were 100.0 ± 2.4% (mean ± S.E.M., N=4) for vehicle, 327.6 ± 3.3% (N=4, **P < 0.01 vs. vehicle) for rotenone (0.5 µM, 3 h), 122.2 ± 4.5% (N=4, **P < 0.01 vs. vehicle) for 3-nitropropionic acid (10 mM, 3 h), 310.5 ± 4.6% (N=4, **P < 0.01 vs. vehicle) for antimycin A (30 µM, 3 h), and 16.1 ± 0.6% (N=4, **P < 0.01 vs. vehicle) for sodium azide (50 mM, 3 h).
Effect of various antioxidants on VCM-induced cell damage in LLC-PK1 cells
The ability of various antioxidants to attenuate VCM-induced proximal tubular epithelial cell injury was investigated. As shown in Fig. 6 , treatment with the lipophilic antioxidant vitamin E (30-100 μM) and the mitochondria-targeted antioxidant mitoTEMPO (3-10 μM) significantly suppressed VCM-induced cell apoptosis, whereas administration of water-soluble antioxidants, such as vitamin C (30-100 μM), NAC (100-300 μM), and GSH (10-30 μM), did not protect against cell damage in LLC-PK1 cells. The VCM-induced release of cytochrome c from the mitochondria to the cytoplasm and caspase-3/7 activity in LLC-PK1 cells were also significantly suppressed by administration of vitamin E (100 μM) and mitoTEMPO (10 μM).
Discussion
Nephrotoxicity is a major common complaint of VCM therapy; however, the exact mechanisms underlying VCM-associated nephrotoxicity remain unclear. In vivo studies have suggested that VCM causes proximal tubular cell injury and possible oxidative stress associated with nephrotoxicity (Cetin et al., 2007; Oktem et al., 2005; Dieterich et al., 2009) . We previously showed (Arimura et al., 2012) that VCM induced apoptosis in LLC-PK1 cells by increasing intracellular reactive oxygen species generation and depolarizing the mitochondrial membrane, followed by activation of caspase-9 and −3/7. Consistent with our previous findings, we observed in the present study that VCM treatment decreased cell viability and induced apoptosis Fig. 3 . VCM-induced mitochondrial cardiolipin peroxidation in LLC-PK1 cells. Cardiolipin peroxidation was assessed using the cardiolipin-specific fluorescent dye NAO. Cells were treated with VCM (4 mM) for the indicated times in the absence or presence of FCCP (0.5 µM) and visualized under a florescence microscope. Data were calculated as the average value for five fields and shown as the mean ± S.E.M. of four experiments. *P < 0.05, **P < 0.01 vs. vehicle, † †P < 0.01 vs. VCM alone. Fig. 4 . VCM-induced changes in (A) mitochondrial membrane potential and (B) cellular ATP content. Cells were treated with VCM (4 mM) for the indicated times in the absence or presence of FCCP (0.5 µM), and membrane potential and ATP levels were determined using a JC-1 assay kit or ATP assay kit, respectively. Data represent the mean ± S.E.M. of four experiments. *P < 0.05, **P < 0.01 vs. vehicle, †P < 0.05, † †P < 0.01 vs. VCM alone.
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European Journal of Pharmacology 800 (2017) [48] [49] [50] [51] [52] [53] [54] [55] [56] through release of cytochrome c from the mitochondria to the cytoplasm (Fig. 1 ). The present study was carried out with the concentrations of 1-5 mM VCM, which are equal to approximately 1.5-7.5 mg/ml and seem to be higher than the plasma concentration of VCM. The clinical target range for VCM trough levels is 10-20 µg/ml (15-20 µg/ml for complicated infections), in which peak levels are found to be exceed 40-50 µg/ml (Rybak et al., 2009; Matzke et al., 1986) . It has also been shown that the concentration of kidney tissue (243 µg/ml) was 45.8 times higher than serum level (5.3 µg/ml), because approximately 80% of administrated dose of VCM is excreted unchanged in urine within 24 h (Matzke et al., 1986) . Therefore, it seems to be by no means high as compared with the concentration of proximal tubular cell in patients with VCM-associated nephrotoxicity.
To amplify the action of VCM, we used 4 mM VCM in the subsequent study where the mechanisms of cell death were determined. As shown in Fig. 2 , VCM increased the fluorescence intensity of DCF and MitoSOX over time. Carboxy-H 2 DCFDA is converted to its fluorescent form, DCF, by intracellular reactive oxygen species, whereas MitoSOX is a selective indicator for mitochondrial superoxide that is taken up by mitochondria and is oxidized by mitochondrial superoxide, resulting in red fluorescence (Purdey et al., 2015; Mukhopadhyay et al., 2007; Ma et al., 2011) . Our findings suggest that VCM induced mitochondrial superoxide production in LLC-PK1 cells as assessed by MitoSOX red, leading to formation of hydrogen peroxide as assessed by DCF. Mitochondria are the main sources of cellular reactive oxygen species generation, and the respiratory chain of the mitochondrial membrane, especially complexes I and III, is a prime site for superoxide generation (Lu et al., 2015; Dröse and Brandt, 2008; Kussmaul and Hirst, 2006) . In the present study, we confirmed that the electron transport inhibitors including rotenone (complex I inhibitor), 3-nitropropionic acid (complex II inhibitor), antimycin A (complex III inhibitor) and sodium azide (complex IV inhibitor) caused apoptosis and change of the mitochondrial superoxide production in LLC-PK1 cells. Only sodium azide decreased the superoxide production; how- ever, those data indicated that all of the electron transport inhibitors such as rotenone, 3-nitropropionic acid, antimycin A and sodium azide caused cell apoptosis in LLC-PK1 cells. Especially, it is likely that rotenone and antimycin A mimicked the VCM-induced LLC-PK1 cell injury such as the superoxide production leading to apoptosis. We previously reported that VCM inhibited mitochondrial complex I activity similarly to the complex I inhibitor rotenone, with similar induction of cell damage in LLC-PK1 cells (Arimura et al., 2012) . Mitochondria complex I might thus be involved in superoxide generation in VCM-induced proximal tubular epithelial cell apoptosis. In contrast, cytochrome c release from the mitochondria to the cytoplasm is a central event in apoptosis induction that is mediated by caspases (Ott et al., 2007) . Cytochrome c is bound to the outer surface of inner membrane phospholipids and primarily to cardiolipin, which plays an important role in mediating cytochrome c release (Ott et al., 2007; Orrenius, 2007; Hanske et al., 2012) . Cytochrome c catalyzes cardiolipin oxidation in the presence of reactive oxygen species, which than contributes to mitochondrial membrane permeabilization (Ott et al., 2007; Orrenius, 2007; Hanske et al., 2012) . It has also been reported that reactive oxygen species-induced cardiolipin oxidation impairs complex I activity (Paradies et al., 2004) . Therefore, we investigated the role of cardiolipin in VCM-induced cell damage in LLC-PK1 cells in the present study. We observed for the first time that VCM increases cardiolipin peroxidation in LLC-PK1 cells over time (Fig. 3A) . Moreover, administration of the mitochondria uncoupler FCCP completely reversed the VCM-induced decrease in NAO fluorescence intensity (Fig. 3B) . FCCP is a protonophore that dissipates the proton gradient of the mitochondrial membrane, followed by uncoupling ATP synthesis from mitochondrial electron transport and inhibition of superoxide production (Dlasková et al., 2008; To et al., 2010) . Here, we observed that treatment of cells with 0.5 µM FCCP alone slightly reduced mitochondrial membrane potential (Fig. 4A ) and superoxide production ( Fig. 5A ) and significantly decreased cellular ATP levels (Fig. 4B) , while FCCP alone did not induce cell apoptosis (Fig. 5C) . Notably, FCCP administration significantly suppressed VCM-induced cell death pathways, including cardiolipin peroxidation (Fig. 3B) , mitochondrial membrane depolarization (Fig. 4A) , intracellular reactive oxygen species generation, and apoptosis (Fig. 5 ) in LLC-PK1 cells. Peroxidation of cardiolipin subsequent to mitochondrial reactive oxygen species generation may be one of the critical events initiating VCM- Fig. 6 . Effects of various antioxidants on (A and B) VCM-induced apoptosis, (C) activation of caspase-3/7, and (D) release of cytochrome c in LLC-PK1 cells. Cells were treated with VCM (4 mM) for the indicated times. mitoTEMPO (3-10 μM), vitamin E (30-100 μM), vitamin C (30-100 μM), NAC (100-300 μM), GSH (10-30 μM), and caspase inhibitors including zDEVD-fmk (a caspase-3-specific inhibitor, 30 μM) and zLEHD-fmk (a caspase-9-specific inhibitor, 30 μM) were added 30 min before VCM treatment and incubated with the cells throughout the experiment. Data represent the mean ± S.E.M. of four experiments. **P < 0.01 vs. vehicle, †P < 0.05, † †P < 0.01 vs. VCM alone.
induced apoptosis in LLC-PK1 cells. Peroxidation of cardiolipin by VCM-induced reactive oxygen species also likely affects respiratory chain complex activity and may generate additional intracellular reactive oxygen species, including superoxide radicals. However, the depletion of ATP was augmented by administration of both VCM and FCCP, suggesting that depletion of ATP may not cause cell injury, but rather may be a result of VCM-induced cell injury. Taken together, our findings indicate that cardiolipin peroxidation mediated the VCMinduced intracellular reactive oxygen species generation and initiation of apoptosis in LLC-PK1 cells.
In this study, vitamin E and mitoTEMPO significantly suppressed VCM-induced mitochondrial membrane depolarization and apoptotic cell death, whereas vitamin C, NAC, and GSH did not significantly protect against VCM-induced LLC-PK1 cell damage (Fig. 6) . Several studies in rats have suggested that antioxidants mitigate VCM-induced kidney damage (Cetin et al., 2007; Oktem et al., 2005; Ocak et al., 2007) , although the exact mechanisms remain unclear. Ocak et al. (2007) compared the beneficial effects of vitamin E, vitamin C, NAC, and caffeic acid phenethyl ester against VCM-induced nephrotoxicity and found that vitamin E was the most effective at preventing VCMinduced tubular damage in rats. It has also reported that hexamethylenediamine-conjugated superoxide dismutase (SOD), which is targeted to renal proximal tubule cells, inhibited VCM-induced renal tissue damage in rats, whereas a non-targeted Cu/Zn-type SOD exhibited no such effect (Nishino et al., 2003) . Superoxide anion is the primary reactive oxygen species generated by the mitochondrial electron transport chain and is converted to hydrogen peroxide by SOD. The resulting hydrogen peroxide is subsequently scavenged by antioxidant enzymes, such as catalase (Lu et al., 2015) . Although GSH and NAC are popular antioxidants and NAC increases intracellular GSH levels, NAC reacts with hydroxyl radical and slowly with hydrogen peroxide, and it is poorly reactive with superoxide (Aruoma et al., 1989) . Vitamin C is also a powerful antioxidant, but it is water-soluble and can only enter mitochondria via facilitative glucose transporter 1 (Sagun et al., 2005) . In contrast, vitamin E is a major lipid-soluble antioxidant and is ideally localized within mitochondrial membranes to offer protection against reactive oxygen species produced continuously within the mitochondria (Vatassery, 2004) . The previous studies and present findings, taken together, show that vitamin E is more effective than water-soluble antioxidants against VCM-induced apoptosis in proximal tubular epithelial cells.
MitoTEMPO is a mitochondria-targeted SOD mimetic that effectively scavenges mitochondrial superoxide (Nazarewicz et al., 2013) and accumulates in mitochondria by ten-fold over cytoplasmic levels (Dikalova et al., 2010) . In this study, 100 µM vitamin E significantly and completely suppressed VCM-induced generation of intracellular reactive oxygen species and mitochondrial superoxide, respectively (Fig. 2) . Similar effects observed with 100 μM vitamin E involving scavenging of VCM-induced mitochondrial reactive oxygen species were observed following administration of low concentrations (10 μM) of mitoTEMPO (data not shown). Notably, vitamin E and mitoTEMPO not only suppressed intracellular reactive oxygen species production but were also effective against VCM-induced injury in LLC-PK1 cells, such as the release of cytochrome c from the mitochondria to the cytoplasm, caspase activation, and apoptosis (Fig. 6) . Moreover, the effective concentration of mitoTEMPO (3-10 μM) against VCM-induced cell injury was one-tenth of the effective concentration of vitamin E (30-100 μM). These results suggest that agents capable of suppressing mitochondrial superoxide would be useful for prophylaxis of VCM-induced proximal tubular epithelial cell injury. We are just making in vivo model using rats to demonstrate the mechanisms underlying the VCM-induced nephrotoxicity and to examine whether mitochondria-targeted antioxidants can reduce the proximal tubular damage caused by VCM. The administration of VCM (200 mg/kg, i.p., twice daily) caused a marked increase in urinary NAG activity, a biomarker of proximal tubular cell damage, at five days after beginning of administration of VCM in rats. The values were 32.6 ± 3.8 units/g creatinine (mean ± S.E.M., N=4) for vehicle, 71.8 ± 5.7 units/g creatinine (N=4, **P < 0.01 vs. vehicle) for VCM. The effectiveness and/or safety of mitoTEMPO against VCM-induced nephrotoxicity in vivo remains unknown; however, low doses of mitochondria-targeted agents such as mitoTEMPO would likely be effective at scavenging mitochondrial reactive oxygen species and improving mitochondrial function. Therefore, mitochondria-targeted antioxidants may be capable of ameliorating VCM-induced nephrotoxicity in vivo.
Conclusions
We report here for the first time that cardiolipin peroxidation mediates VCM-induced intracellular reactive oxygen species production and initiation of apoptosis in proximal tubular epithelial cells. Moreover, the effective scavenging of mitochondrial reactive oxygen species by the lipophilic antioxidant vitamin E and the mitochondriatargeted antioxidant mitoTEMPO improved mitochondrial function, and may constitute a potential strategy for mitigation of VCM-induced proximal tubular epithelial cell injury.
